3m ago
KUALA LUMPUR, Sept 24 (Bernama) -- Budget 2025, to be tabled in the Dewan Rakyat on Oct 18, is expected to strike a balanced approach, combining fiscal sustainability with initiatives to drive economic development, said RHB Investment Bank (IB) Bhd.
3m ago
KUALA LUMPUR, Sept 24 (Bernama) -- The Malaysian Consultative Council of Islamic Organisations (MAPIM) has called on all parties, regardless of political ideology, to support the MADANI Government’s efforts to revitalise and strengthen the national economy in the current situation where the ringgit continues to strengthen.
3m ago
GEORGE TOWN, Sept 24 (Bernama) -- Affin Bank Bhd expects Malaysia’s gross domestic product (GDP) growth to remain healthy at five per cent this year and 5.2 per cent next year amidst the low possibility of a global recession.
4m ago
KUALA LUMPUR, Sept 23 (Bernama) -- Malaysia’a fiscal deficit target of three per cent by 2026 “remains challenging but achievable,” according to Malaysian Rating Corporation Bhd (MARC).
4m ago
KUALA LUMPUR, Sept 20 (Bernama) -- Malaysia has officially ratified the United Kingdom's (UK) accession to the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP), a significant milestone as it is effectively Malaysia’s first bilateral free trade agreement with the UK.
4m ago
KUALA LUMPUR, Sept 19 (Bernama) -- Malaysia’s RM160 billion approved investments in the first half of 2024 (1H 2024), comprising RM85.4 billion in domestic investments (DI) and RM74.6 billion in foreign investments (FI), showed that the country is not overly dependent on FI to stimulate its economy.
4m ago
KUALA LUMPUR, Sept 19 (Bernama) -- Malaysia’s trade has continued its stellar performance in August, growing 18.6 per cent year-on-year to RM252.65 billion -- the fastest growth rate in 22 months, according to the Investment, Trade and Industry Ministry (MITI).
4m ago
By Durratul Ain Ahmad Fuad
KUALA LUMPUR, Sept 15 (Bernama) – Integrated biotech group ALPS Global Holding Bhd, which is en route to a Nasdaq listing in the fourth quarter of 2024, aims to raise US$100 million to fund its expansion, clinical studies, and manufacturing plant.